EUVIMEDEUVIMED entdecken
Open Access

Surrogate Adiposity Markers and Mortality

Irfan Khan, Michael Chong, Ann Le, Pedrum Mohammadi-Shemirani, Robert Morton, Christina Brinza, Michel Kiflen, Sukrit Narula, Loubna Akhabir, Shihong Mao, Katherine Morrison, Marie Pigeyre und 1 weitere

JAMA Network Open · 20.09.2023 · 6 (9) · e2334836

DOI: 10.1001/jamanetworkopen.2023.34836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 20.09.2023. Verfasst von Irfan Khan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Adiposity, Obesity. Die Arbeit wurde bisher 191-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Body mass index (BMI) is an easily obtained adiposity surrogate. However, there is variability in body composition and adipose tissue distribution between individuals with the same BMI, and there is controversy regarding the BMI associated with the lowest mortality risk.

Objective

To evaluate which of BMI, fat mass index (FMI), and waist-to-hip (WHR) has the strongest and most consistent association with mortality. Design, Setting, and Participant This cohort study used incident deaths from the UK Biobank (UKB; 2006-2022), which includes data from 22 clinical assessment centers across the United Kingdom. UKB British participants of British White ancestry (N = 387 672) were partitioned into a discovery cohort (n = 337 078) and validation cohort (n = 50 594), with the latter consisting of 25 297 deaths and 25 297 controls. The discovery cohort was used to derive genetically determined adiposity measures while the validation cohort was used for analyses. Exposure-outcome associations were analyzed through observational and mendelian randomization (MR) analyses. Exposures BMI, FMI, and WHR. Main Outcomes and Measures All-cause and cause-specific (cancer, cardiovascular disease [CVD], respiratory disease, or other causes) mortality.

Results

There were 387 672 and 50 594 participants in our observational (mean [SD] age, 56.9 [8.0] years; 177 340 [45.9%] male, 210 332 [54.2%], female), and MR (mean [SD] age, 61.6 [6.2] years; 30 031 [59.3%] male, 20 563 [40.6%], female) analyses, respectively. Associations between measured BMI and FMI with all-cause mortality were J-shaped, whereas the association of WHR with all-cause mortality was linear using the hazard ratio (HR) scale (HR per SD increase of WHR, 1.41 [95% CI, 1.38-1.43]). Genetically determined WHR had a stronger association with all-cause mortality than BMI (odds ratio [OR] per SD increase of WHR, 1.51 [95% CI, 1.32-1.72]; OR per SD increase of BMI, 1.29 [95% CI, 1.20-1.38]; P for heterogeneity = .02). This association was stronger in male than female participants (OR, 1.89 [95% CI, 1.54-2.32]; P for heterogeneity = .01). Unlike BMI or FMI, the genetically determined WHR–all-cause mortality association was consistent irrespective of observed BMI. Conclusions and Relevance In this cohort study, WHR had the strongest and most consistent association with mortality irrespective of BMI. Clinical recommendations should consider focusing on adiposity distribution compared with mass.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdiposityObesityHumansFemaleMaleMiddle AgedCohort StudiesBody Fat DistributionBiomarkers

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Population Health Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute, Hamilton, Ontario, Canada.
  • Thrombosis and Atherosclerosis Research Institute, David Barley Cardiac, Vascular and Stroke Research, Hamilton, Ontario, Canada.
  • Department of Pathology and Molecular Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • College of Medicine and Health, University College Cork, Cork, Ireland.
  • School of Medicine, Queen's University, Kingston, Ontario, Canada.

Zitieren

APA

Khan, I., Chong, M., Le, A., Mohammadi-Shemirani, P., Morton, R., Brinza, C., Kiflen, M., Narula, S., Akhabir, L., Mao, S., Morrison, K., Pigeyre, M., & Paré, G. (2023). Surrogate Adiposity Markers and Mortality. JAMA Network Open, 6(9), e2334836. https://doi.org/10.1001/jamanetworkopen.2023.34836

Vancouver

Khan I, Chong M, Le A, Mohammadi-Shemirani P, Morton R, Brinza C, et al. Surrogate Adiposity Markers and Mortality. JAMA Network Open. 2023;6(9):e2334836. doi:10.1001/jamanetworkopen.2023.34836

BibTeX
@article{Khan2023,
  author = {Khan, Irfan and Chong, Michael and Le, Ann and Mohammadi-Shemirani, Pedrum and Morton, Robert and Brinza, Christina and Kiflen, Michel and Narula, Sukrit and Akhabir, Loubna and Mao, Shihong and Morrison, Katherine and Pigeyre, Marie and Paré, Guillaume},
  title = {Surrogate Adiposity Markers and Mortality},
  journal = {JAMA Network Open},
  year = {2023},
  volume = {6},
  number = {9},
  pages = {e2334836},
  doi = {10.1001/jamanetworkopen.2023.34836}
}
Kostenlos starten →